BLCO
Bausch & Lomb CorpPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Mar 3 to Mar 6 ▲ 2 days of insider buys: $650.4K by 4 insiders, avg $17.21
- Aug 6 to Aug 10 ▼ 3 days of insider sells: $1.2M by 2 insiders, avg $16.71
- Aug 10 Trial readout: Results Pending: BL1107 Low dose (Phase 2), Completed 84d…
- Aug 11 Trial readout: Results Pending: BL1107 Low dose (Phase 2), Completed 85d…
- Aug 11 Trial readout: Results Pending: Lifitegrast/Perfluorohexyloctane Fixed Do…
- Aug 25 Trial readout: Results Pending: Lifitegrast/Perfluorohexyloctane Fixed Do…
- Oct 1 Gemini Insurance Company v. Bausch & Lomb Americas, Inc.
- Oct 13 Bausch + Lomb CEO Brent Saunders has mutually agreed to depart, effe…
- Oct 22 Trial readout: Results Pending: Topical Ocular BL1332 low dose (Phase 2),…
- Oct 28 ▲ Bausch + Lomb reported Q3 2026 revenue of $1.375B (+7% YoY) and GAAP…
- Oct 29 ▼ 1 insider sell $2.3M at $20.48
- Nov 2 ▼ HC Wainwright & Co. downgrades
Signal stack
Where each data set points today.
- InsidersBEARISH
4 insiders bought $650.4K at an average $17.21. 2 insiders sold $3.5M. Price is 21% above their cost.
- InstitutionsMIXED
Q3 2026: 6 added (0 new), 8 trimmed or exited.
- AnalystsBULLISH
11 of 19 rate it Buy or better. Median target $22.00 (+5%).
- Short sellersSTEADY
Short interest +1.9% to 2.59M shares. 2.3 days to cover, ≈0.7% of shares.
- TrendUPTREND
16% above its 50-day average. New closing high $21.37 on Nov 10.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| ICAHN CARL C | TRIM | $40.4M |
| UBS Group AG | TRIM | $5.7M |
| JPMORGAN CHASE & CO | DOUBLED | $5.1M |
| BNP PARIBAS FINANCIAL MARKETS | ADD | $4.1M |
| Jump Financial, LLC | NEAR_EXIT | $328.1K |
| SIMPLEX TRADING, LLC | NEAR_EXIT | $19.4K |
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | $35.8M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | ADD | $22.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
19 analystsPrice is inside the target range. Median implies +5%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 2, 2026 | HC Wainwright & Co. DOWNGRADE | Neutral |
| Oct 29, 2026 | JP Morgan MAINTAIN | Neutral |
| Oct 29, 2026 | Citigroup MAINTAIN | Buy |
| Oct 29, 2026 | RBC Capital MAINTAIN | Outperform |
| Oct 29, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Oct 7, 2026 | Barclays INITIATE | Overweight |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Alfonso Eduardo Director Oct 29, 2026 | AWARD | $22.9K |
Munsch Frederick SVP, Controller and CAO Oct 29, 2026 | EXERCISE | $1.6M |
Munsch Frederick SVP, Controller and CAO Oct 29, 2026 | SELL | $2.3M |
Munsch Frederick SVP, Controller and CAO Oct 29, 2026 | EXERCISE | $432.9K |
Paulson John Director Oct 29, 2026 | AWARD | $22.9K |
ROBERTSON RUSSEL C Director Oct 29, 2026 | AWARD | $25.6K |
Trebbi Barbara Director Aug 12, 2026 | AWARD | 11,776 sh |
Chersi Robert J Director Aug 12, 2026 | AWARD | 11,776 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
24 filings · 5 bullish · 0 bearish · 2 mixed · 17 neutral- NEUTRAL 144Nov 12, 2026
Former director Karen Ling filed a Form 144 notice to sell 12,838 common shares of Bausch & Lomb…
This is a small, routine sale by a former director. No material impact expected. Monitor for any additional insider selling patterns in future filings.
- NEUTRAL 144Nov 3, 2026
Nathalie D. Bernier, a former director of Bausch & Lomb Corp, filed a Form 144 notice of intent to…
The sale is small relative to market cap and involves a former director, not current management. No material signal for the stock. Monitor for any additional insider selling patterns in the coming…
- NEUTRAL 144Oct 29, 2026
Frederick Munsch, an officer of Bausch & Lomb Corp, filed a Form 144 notice of intent to sell…
The filing is an advance notice of intent to sell; the actual sale may or may not occur. Monitor subsequent Form 4 filings to confirm execution and assess whether this is a one-time liquidity event…
- NEUTRAL 8-KOct 28, 2026
Director Nathalie Bernier resigned from the Bausch + Lomb board and its Science and Technology…
A single director resignation with no disagreement and no plan to fill the seat is routine. Monitor for any future board changes or Science and Technology Committee composition updates, but no…
All BLCO filing & press-release reports (24)
- 144 reportNov 12, 2026
- 144 reportNov 3, 2026
- 144 reportOct 29, 2026
- 8-K reportOct 28, 2026
- 8-K reportOct 28, 2026
- 8-K reportOct 13, 2026
- COURT-RULING reportOct 1, 2026
- 144 reportSep 28, 2026
- CLUSTER reportAug 12, 2026
- 3 reportAug 14, 2026
- 3, CLUSTER reportAug 14, 2026
- 3 reportAug 14, 2026
- CLUSTER reportAug 12, 2026
- 144 reportAug 7, 2026
- 144 reportAug 6, 2026
- 8-K reportAug 6, 2026
- 8-K reportJul 29, 2026
- CLUSTER reportFeb 27, 2026
- CLUSTER reportFeb 27, 2026
- CLUSTER reportFeb 20, 2026
- CLUSTER reportFeb 20, 2026
- CLUSTER reportFeb 20, 2026
- CLUSTER reportFeb 20, 2026
- CLUSTER reportFeb 20, 2026